Michael Y Tsai Selected Research

cis-vaccenic acid

6/2014	Plasma cis-vaccenic acid and risk of heart failure with antecedent coronary heart disease in male physicians.
11/2012	Plasma phospholipid concentration of cis-palmitoleic acid and risk of heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Y Tsai Research Topics

Disease

79	Atherosclerosis 01/2022 - 02/2006
38	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2005
28	Coronary Disease (Coronary Heart Disease) 03/2021 - 02/2009
20	Inflammation (Inflammations) 01/2021 - 06/2005
14	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2022 - 12/2014
13	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2002
13	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2021 - 08/2002
13	Heart Failure 07/2021 - 10/2012
13	Insulin Resistance 10/2020 - 03/2009
12	Hypertension (High Blood Pressure) 07/2017 - 03/2008
10	Obesity 01/2020 - 01/2007
7	Dyslipidemias (Dyslipidemia) 01/2021 - 08/2002
7	Venous Thromboembolism 04/2009 - 04/2002
6	Atrial Fibrillation 01/2021 - 04/2013
6	Hearing Loss (Hearing Impairment) 12/2020 - 06/2012
5	Diabetes Mellitus 01/2021 - 09/2010
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2017 - 08/2002
4	Cognitive Dysfunction 01/2020 - 06/2012
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 07/2004
4	Hyperlipidemias (Hyperlipidemia) 09/2010 - 08/2008
3	Birth Weight (Birth Weights) 01/2022 - 10/2021
3	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 04/2014
3	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2021 - 01/2017
3	Aortic Valve Disease 03/2021 - 01/2016
3	Albuminuria 01/2019 - 01/2008
3	Pre-Eclampsia (Preeclampsia) 01/2019 - 12/2014
3	Carotid Artery Diseases 01/2019 - 05/2007
3	Peripheral Arterial Disease 05/2017 - 04/2015
2	Chronic Renal Insufficiency 10/2021 - 06/2010
2	Hypertrophy 07/2021 - 06/2004
2	Aortic Valve Stenosis (Aortic Stenosis) 11/2020 - 01/2020
2	Vitamin D Deficiency 01/2019 - 09/2013
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 04/2014
2	Myocardial Infarction 01/2018 - 06/2014
2	Stroke (Strokes) 01/2018 - 11/2016
2	Premature Birth (Birth, Premature) 06/2017 - 12/2014
2	Overweight 03/2016 - 03/2010

Drug/Important Bio-Agent (IBA)

30	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2005
27	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 08/2007
23	LipidsIBA 10/2021 - 06/2005
18	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022 - 08/2007
17	CalciumIBA 01/2022 - 02/2006
15	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022 - 11/2010
13	Lipoprotein(a)IBA 01/2022 - 04/2015
13	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2022 - 12/2006
13	Interleukin-6 (Interleukin 6)IBA 10/2021 - 01/2006
12	CholesterolIBA 10/2021 - 03/2005
12	HDL CholesterolIBA 01/2020 - 01/2006
11	C-Reactive ProteinIBA 01/2021 - 06/2005
11	oxidized low density lipoproteinIBA 01/2021 - 05/2007
11	Lipoproteins (Lipoprotein)IBA 01/2019 - 01/2008
10	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 01/2008
10	Triglycerides (Triacylglycerol)IBA 06/2017 - 08/2002
9	Docosahexaenoic AcidsIBA 01/2022 - 12/2006
8	Eicosapentaenoic AcidIBA 01/2022 - 12/2006
8	LDL CholesterolIBA 01/2021 - 06/2006
8	HomocysteineIBA 01/2020 - 03/2003
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2009
6	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2019 - 07/2015
6	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 01/2019 - 01/2011
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021 - 08/2013
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2014 - 09/2009
4	Retinaldehyde (Retinal)IBA 01/2022 - 01/2006
4	ApolipoproteinsIBA 01/2021 - 09/2017
4	Insulin (Novolin)FDA Link 10/2020 - 05/2015
4	AdiponectinIBA 01/2019 - 03/2009
4	Arachidonic Acid (Vitamin F)IBA 01/2019 - 01/2015
4	CreatinineIBA 01/2019 - 06/2004
4	Fibrinogen (Factor I)FDA Link 02/2016 - 01/2007
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2015 - 06/2010
4	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 04/2014 - 09/2009
4	Fenofibrate (CiL)FDA LinkGeneric 03/2012 - 05/2008
3	Nonesterified Fatty Acids (NEFA)IBA 07/2021 - 04/2015
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 12/2017
3	Apolipoproteins B (ApoB)IBA 01/2020 - 09/2017
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2019 - 06/2010
3	Apolipoprotein C-IIIIBA 01/2019 - 03/2005
3	palmitoleic acidIBA 10/2018 - 11/2012
3	HDL LipoproteinsIBA 01/2018 - 12/2011
3	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2018 - 08/2011
3	SelectinsIBA 01/2016 - 06/2014
2	Biological ProductsIBA 01/2022 - 07/2009
2	Trans Fatty AcidsIBA 01/2022 - 04/2013
2	fibrin fragment D (D-dimer)IBA 11/2021 - 02/2016
2	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2021 - 09/2010
2	pro-brain natriuretic peptide (1-76)IBA 07/2021 - 09/2010
2	EnzymesIBA 10/2020 - 03/2016
2	Insulin-Like PeptidesIBA 01/2020 - 11/2016
2	AldosteroneIBA 01/2020 - 01/2019
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020 - 01/2019
2	AdipokinesIBA 01/2020 - 01/2019
2	Linoleic Acid (Linoleate)IBA 01/2019 - 12/2017
2	Vitamin D FDA LinkGeneric 01/2019 - 09/2013
2	AlbuminsIBA 01/2019 - 03/2008
2	Oleic Acid (Oleate)IBA 11/2018 - 11/2012
2	Scavenger Receptors (Scavenger Receptor)IBA 01/2018 - 05/2009
2	ABO Blood-Group SystemIBA 05/2017 - 01/2016
2	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 03/2016 - 12/2009

Therapy/Procedure

7	Therapeutics 01/2022 - 09/2010
2	Drug Therapy (Chemotherapy) 12/2016 - 02/2006